These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 23049074

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Receptor-recognized α₂-macroglobulin binds to cell surface-associated GRP78 and activates mTORC1 and mTORC2 signaling in prostate cancer cells.
    Misra UK, Pizzo SV.
    PLoS One; 2012; 7(12):e51735. PubMed ID: 23272152
    [Abstract] [Full Text] [Related]

  • 3. Cystogenesis and elongated primary cilia in Tsc1-deficient distal convoluted tubules.
    Armour EA, Carson RP, Ess KC.
    Am J Physiol Renal Physiol; 2012 Aug 15; 303(4):F584-92. PubMed ID: 22674026
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. mTORC2 is required for proliferation and survival of TSC2-null cells.
    Goncharova EA, Goncharov DA, Li H, Pimtong W, Lu S, Khavin I, Krymskaya VP.
    Mol Cell Biol; 2011 Jun 15; 31(12):2484-98. PubMed ID: 21482669
    [Abstract] [Full Text] [Related]

  • 9. Raptor downregulation rescues neuronal phenotypes in mouse models of Tuberous Sclerosis Complex.
    Karalis V, Caval-Holme F, Bateup HS.
    Nat Commun; 2022 Aug 09; 13(1):4665. PubMed ID: 35945201
    [Abstract] [Full Text] [Related]

  • 10. Fetal brain mTOR signaling activation in tuberous sclerosis complex.
    Tsai V, Parker WE, Orlova KA, Baybis M, Chi AW, Berg BD, Birnbaum JF, Estevez J, Okochi K, Sarnat HB, Flores-Sarnat L, Aronica E, Crino PB.
    Cereb Cortex; 2014 Feb 09; 24(2):315-27. PubMed ID: 23081885
    [Abstract] [Full Text] [Related]

  • 11. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.
    Zeng LH, Rensing NR, Zhang B, Gutmann DH, Gambello MJ, Wong M.
    Hum Mol Genet; 2011 Feb 01; 20(3):445-54. PubMed ID: 21062901
    [Abstract] [Full Text] [Related]

  • 12. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells.
    Gordon BS, Kazi AA, Coleman CS, Dennis MD, Chau V, Jefferson LS, Kimball SR.
    Cell Signal; 2014 Mar 01; 26(3):461-7. PubMed ID: 24316235
    [Abstract] [Full Text] [Related]

  • 13. Mechanistic target of rapamycin complex 2 protects the heart from ischemic damage.
    Völkers M, Konstandin MH, Doroudgar S, Toko H, Quijada P, Din S, Joyo A, Ornelas L, Samse K, Thuerauf DJ, Gude N, Glembotski CC, Sussman MA.
    Circulation; 2013 Nov 05; 128(19):2132-44. PubMed ID: 24008870
    [Abstract] [Full Text] [Related]

  • 14. Tumor suppressors TSC1 and TSC2 differentially modulate actin cytoskeleton and motility of mouse embryonic fibroblasts.
    Goncharova EA, James ML, Kudryashova TV, Goncharov DA, Krymskaya VP.
    PLoS One; 2014 Nov 05; 9(10):e111476. PubMed ID: 25360538
    [Abstract] [Full Text] [Related]

  • 15. Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology.
    Thomanetz V, Angliker N, Cloëtta D, Lustenberger RM, Schweighauser M, Oliveri F, Suzuki N, Rüegg MA.
    J Cell Biol; 2013 Apr 15; 201(2):293-308. PubMed ID: 23569215
    [Abstract] [Full Text] [Related]

  • 16. Selective disruption of mTORC1 and mTORC2 in VTA astrocytes induces depression and anxiety-like behaviors in mice.
    Zheng Z, Zhou H, Yang L, Zhang L, Guo M.
    Behav Brain Res; 2024 Apr 12; 463():114888. PubMed ID: 38307148
    [Abstract] [Full Text] [Related]

  • 17. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells.
    Le Bacquer O, Queniat G, Gmyr V, Kerr-Conte J, Lefebvre B, Pattou F.
    J Endocrinol; 2013 Jan 12; 216(1):21-9. PubMed ID: 23092880
    [Abstract] [Full Text] [Related]

  • 18. A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.
    Feliciano DM, Lin TV, Hartman NW, Bartley CM, Kubera C, Hsieh L, Lafourcade C, O'Keefe RA, Bordey A.
    Int J Dev Neurosci; 2013 Nov 12; 31(7):667-78. PubMed ID: 23485365
    [Abstract] [Full Text] [Related]

  • 19. Complex Neurological Phenotype in Mutant Mice Lacking Tsc2 in Excitatory Neurons of the Developing Forebrain(123).
    Crowell B, Lee GH, Nikolaeva I, Dal Pozzo V, D'Arcangelo G.
    eNeuro; 2015 Nov 12; 2(6):. PubMed ID: 26693177
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic inhibition of mTORC2 rescues the behavioral and neurophysiological abnormalities associated with Pten-deficiency.
    Chen CJ, Sgritta M, Mays J, Zhou H, Lucero R, Park J, Wang IC, Park JH, Kaipparettu BA, Stoica L, Jafar-Nejad P, Rigo F, Chin J, Noebels JL, Costa-Mattioli M.
    Nat Med; 2019 Nov 12; 25(11):1684-1690. PubMed ID: 31636454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.